Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ViiV Healthcare
With
MUC Research GmbH
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Greated than or equal to (\>=)18 years of age.
Documented HIV-1 infection.
Virologically suppressed (HIV-1 ribonucleic acid \[RNA\] less than \[\<\] 50 copies \[c\]/mL for at least 6 months)
Prescription for JULUCA was issued independently from entering this study.
Ability to understand informed consent form and other relevant study documents
You may not be if
Any contraindication according to JULUCA SmPC.
Documented viral load greater than (\>) 50 c/mL at any time point within 6 months prior to inclusion into this study.
History of treatment failure.
Known or suspected substitutions associated with resistance to any non-nucleoside reverse-transcriptase inhibitors (NNRTI) or integrase strand transfer inhibitor (INSTI).
Any ART for the treatment of HIV-1 in addition to JULUCA.
Hepatitis B virus (HBV)-co-infection.
Current participation in the ongoing non-interventional study TRIUMPH (study number: 202033) or any interventional clinical trial irrespective of indication.
Previous participation in clinical trials involving JULUCA.
